What with the underwhelming market response to my previous article discussing the effect of the 2010 federal Patient Protection and Affordable Care Act (PPACA) on health insurers, I was pretty astonished (and relieved) to see Citigroup equity strategist Tobias Levkovich state many of the concerns which have occupied me.
Please read my latest column at Forbes.com's The Apothecary.
Research and commentary from a former senior executive in the U.S. Department of Health & Human Services
No comments:
Post a Comment